0001415889-24-007503.txt : 20240311 0001415889-24-007503.hdr.sgml : 20240311 20240311161538 ACCESSION NUMBER: 0001415889-24-007503 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240308 FILED AS OF DATE: 20240311 DATE AS OF CHANGE: 20240311 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tasse Daniel CENTRAL INDEX KEY: 0001502785 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36697 FILM NUMBER: 24738219 MAIL ADDRESS: STREET 1: C/O IKARIA, INC. STREET 2: 6 STATE ROUTE 173 CITY: CLINTON STATE: NJ ZIP: 08809 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DBV Technologies S.A. CENTRAL INDEX KEY: 0001613780 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: I0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 177-181 AVENUE PIERRE BROSSOLETTE CITY: MONTROUGE STATE: I0 ZIP: 92120 BUSINESS PHONE: 33(0)155427878 MAIL ADDRESS: STREET 1: 177-181 AVENUE PIERRE BROSSOLETTE CITY: MONTROUGE STATE: I0 ZIP: 92120 4 1 form4-03112024_040312.xml X0508 4 2024-03-08 0001613780 DBV Technologies S.A. DBVT 0001502785 Tasse Daniel C/O DBV TECHNOLOGIES S.A. 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120 FRANCE true true false false CHIEF EXECUTIVE OFFICER 0 Ordinary Shares 2024-03-08 4 P 0 17094 0.83 A 17094 D The Ordinary Shares may be represented by American Depositary Shares ("ADS"), each of which currently represents one-half of one Ordinary Share. Represent the ADS price. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.8123 to $0.8612 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. /s/ Jason Minio, Attorney-in-Fact 2024-03-11